Overview RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY Status: Recruiting Trial end date: 2022-08-30 Target enrollment: Participant gender: Summary This is a randomized, placebo-controlled trial of RT001 in patients with PSP. Phase: Phase 2 Details Lead Sponsor: Retrotope, Inc.